Related Experiment Video
Updated: Jul 14, 2026

Field Identification of Matricaria chamomilla using a Portable qPCR System
Published on: October 10, 2020
General practitioners and St. John's Wort: a question of regulation or knowledge?
H McGarry1, M Pirotta, K Hegarty
1Department of General Practice, University of Melbourne, 200 Berkeley Street, Carlton, Vic. 3053, Australia. h.mcgarry@unimelb.edu.au
Background:
St. John's Wort (SJW), also known as Hypericum perforatum, is a herbal remedy available over-the-counter. There is evidence that it can treat mild to moderate depression but has potential side effects and important drug interactions.
Objective:
To determine general practitioners' (GPs') knowledge and recommendation of SJW for mild to moderate depression within a climate of widespread community use of complementary therapies and debate about regulation.
Design And Setting:
Postal survey of a random sample of 350 Australian GPs.
Results:
Forty-eight percent responded. One-third (31%) reported recommending SJW to patients with mild to moderate depression. Of these, only one-third (32%) reported specific dosage instructions. Respondents' knowledge of side effects and interactions was much less than for selective serotonin reuptake inhibitor antidepressants.
Conclusions:
Australian GPs know less about safety of SJW than antidepressants and do not widely recommend it to patients. Despite this, many patients use SJW, probably in combination with other pharmaceuticals. Effective dissemination of further research into effectiveness and risk profiles of complementary therapies is needed to inform health professionals, regulatory bodies and consumers.
Related Concept Videos
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Classes and Categories
Dosage Regimen: Individualization
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

